Institutional investors hold a majority ownership of GRFS through the 60.03% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2016, these large investors purchased a net $1.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HARDING LOEVNER LP Bought 6.4 Million shares of Grifols SA
CREDIT SUISSE SECURITIES (USA) L... Bought 4.8 Million shares of Grifols SA
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.4 Million shares of Grifols SA